Health and Healthcare

Co-Diagnostics Roars Back With New COVID-19 Test Deal

Kena Betancur / Getty Images News via Getty Images

Co-Diagnostics, Inc. (NASDAQ: CODX) shares shot up on Tuesday after the company announced that it has entered into an agreement with Arches Research to expand Arches’ COVID-19 testing services using Co-Diagnostics’ test kit.

Worth noting is that Arches Research is certified under the Clinical Laboratory Improvement Amendments (CLIA) and is a subsidiary of PolarityTE, Inc, (NASDAQ: PTE).

The agreement centers around Co-Diagnostics’ Logix Smart COVID-19 test kit. Arches Research began using Co-Diagnostics’ tests for its customers earlier this year. The announcement follows news last week of additional, independent third-party validations supporting the test kit’s performance.

The Logix Smart test kit is authorized to be used for the diagnosis of SARS-CoV-2, the virus that causes COVID-19, in the United States and many other countries.

Arches received a CLIA certificate of registration at the end of April and began testing for COVID-19 shortly after. The CLIA is regulated by the Centers for Medicare & Medicaid Services (CMS) with a primary goal to ensure quality laboratory testing.

Excluding Tuesday’s move, Co-Diagnostics’ stock is up over 820% year to date. In the past 52-weeks, the stock is up over 655%.

Co-Diagnostics stock was last seen up about 40% at $11.52, with a 52-week range of $0.85 to $30.99. The consensus analyst price target is $35.33.

PolarityTE was recently trading up about 10% at $1.15, with a 52-week range of $0.78 to $5.08. Analysts have a consensus analyst price target of $3.33 for the stock.

It’s Your Money, Your Future—Own It (sponsor)

Retirement can be daunting, but it doesn’t need to be.

Imagine having an expert in your corner to help you with your financial goals. Someone to help you determine if you’re ahead, behind, or right on track. With SmartAsset, that’s not just a dream—it’s reality. This free tool connects you with pre-screened financial advisors who work in your best interests. It’s quick, it’s easy, so take the leap today and start planning smarter!

Don’t waste another minute; get started right here and help your retirement dreams become a retirement reality.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.

AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.